Early radionuclide therapy delays progression in metastatic prostate cancer
2 sources·Updated August 7, 2026
Covered by 2 sources
- Medical Xpress·9h agoRadiopharmaceutical may benefit patients with metastatic prostate cancer sooner
Earlier use of a targeted radionuclide therapy delays metastatic prostate cancer progression when administered as part of a trio of drugs, according to a Phase III clinical trial led by Weill Cornell Medicine, NewYork-Presbyterian, Memorial Sloan Kettering Cancer Center and…
Read at Medical Xpress → - News-Medical·23h agoEarly radionuclide therapy delays progression in metastatic prostate cancer
Earlier use of a targeted radionuclide therapy delays metastatic prostate cancer progression when administered as part of a trio of drugs, according to a phase 3 clinical trial led by Weill Cornell Medicine, NewYork-Presbyterian, Memorial Sloan Kettering Cancer Center and…
Read at News-Medical →
